ScaleReady
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.scaleready.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ScaleReady
ScaleReady specializes in CGT manufacturing technology, offering the G-Rex platform, which is the only linearly scalable solution from research and development to commercial production. Their technology is utilized by 50% of clinical trial sponsors in the USA and is recognized for its robustness and quality assurance in drug product manufacturing. ScaleReady supports a wide range of applications, including CAR-T cell therapy, and is involved in initiatives like the G-Rex Grant Program to advance cell and gene-modified therapies. The company is well-regarded by regulatory bodies such as the FDA and EMA, ensuring compliance and reliability in the CGT sector.Explore more
ScaleReady Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ScaleReady your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ScaleReady
Check out if ScaleReady is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ScaleReady launches new products
Check if ScaleReady has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ScaleReady has new funding data
Earning: See what the market has to say on ScaleReady recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if ScaleReady had a recent Job posting/layoffs
ScaleReady, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined ScaleReady as Masked Content
Find 2 more new buyers
Compare Similar Companies to ScaleReady
Compare insights from companies similar to ScaleReady, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ScaleReady is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ScaleReady is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ScaleReady.
ScaleReady Tech Stack
A closer look at the technologies used by ScaleReady
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Project
Spending/Investment
Event
Events, Medical Research, Pharmaceuticals, Clinical Operations, Healthcare Operations, Healthcare Technology
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Event
ScaleReady News & Media
ScaleReady 頒發 G-Rex® 資助予優基科技 , 聖保羅市，美國明尼蘇達州， 2025年8月6日
ScaleReady 與 Wilson Wolf Manufacturing、Bio-Techne Corporation 及 CellReady 合作，今日宣布向 優基科技 頒發 15 萬美元的 G-Rex® 資助，以支持建立高效的 cGMP 標準 G-Rex® 為核心的自然殺傷細胞（NK）生產平台 中華人民共和國香港特別行政區, HONG KONG, August 6, 2025 /EINPresswire.com/ -- ScaleReady 與 Wilson Wolf …ScaleReady Announces a G-Rex® Grant has been awarded to Xellera Therapeutics. ST. PAUL, Minn., 6 August, 2025
ScaleReady Announces a G-Rex® Grant has awarded US$150K G-Rex® Grant to support Xellera Therapeutics establish a cGMP centric NK cell manufacturing platform. HONG KONG SAR, CHINA, HONG KONG, August 6, 2025 /EINPresswire.com/ -- ScaleReady, in …OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements
NEW YORK--(BUSINESS WIRE)--OverT Bio, an NYC-based cell therapy company, today announced that it has been awarded a $120,000 G-Rex Grant from ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM. This grant will support OverT Bio’s ongoing development efforts that will lead to next generation cell therapies for solid tumors, based on innovative data-driven discovery platforms OverTargetTM and OverTCRTM. The G-Rex Grant is part ofScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
ST. PAUL, Minn., May 29, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced the launch of the G-Rex® Grant Program, a $20 million initiative to propel the advancement of cell and gene...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ScaleReady
Sign Up For FreeTo access detailed company insights
ScaleReady specializes in CGT manufacturing technology, offering the G-Rex platform, which is the only linearly scalable solution from research and development to commercial production. Their technology is utilized by 50% of clinical trial sponsors in the USA and is recognized for its robustness and quality assurance in drug product manufacturing.... Read More
